(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(-1.22%) $77.99
(5.65%) $2.15
(0.02%) $2 310.10
(-0.16%) $26.79
(0.37%) $966.20
(-0.35%) $0.929
(-1.07%) $10.87
(-0.11%) $0.797
(0.35%) $91.45
Live Chart Being Loaded With Signals
TriSalus Life Sciences, Inc., an immunotherapy company that develops and commercializes immunotherapies for the treatment of liver and pancreatic tumors...
Stats | |
---|---|
Today's Volume | 24 432.00 |
Average Volume | 41 475.00 |
Market Cap | 289.55M |
EPS | $0 ( 2024-04-01 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -1.430 |
ATR14 | $0.0440 (0.45%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-02-13 | Szela Mary T | Buy | 84 899 | Common Stock |
2024-02-13 | Szela Mary T | Buy | 288 750 | Employee Stock Option (right to buy) |
2024-02-12 | Marshak Richard | Buy | 63 750 | Employee Stock Option (right to buy) |
2024-02-12 | Marshak Richard | Buy | 14 752 | Common Stock |
2024-02-12 | Cox Bryan F. | Buy | 14 752 | Common Stock |
INSIDER POWER |
---|
18.37 |
Last 81 transactions |
Buy: 10 554 864 | Sell: 8 042 900 |
Volume Correlation
TriSalus Life Sciences, Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
TriSalus Life Sciences, Correlation - Currency/Commodity
TriSalus Life Sciences, Financials
Annual | 2023 |
Revenue: | $18.51M |
Gross Profit: | $15.91M (85.93 %) |
EPS: | $-6.28 |
FY | 2023 |
Revenue: | $18.51M |
Gross Profit: | $15.91M (85.93 %) |
EPS: | $-6.28 |
FY | 2022 |
Revenue: | $12.40M |
Gross Profit: | $10.14M (81.79 %) |
EPS: | $-1.790 |
Financial Reports:
No articles found.
TriSalus Life Sciences,
TriSalus Life Sciences, Inc., an immunotherapy company that develops and commercializes immunotherapies for the treatment of liver and pancreatic tumors. The company offers the TriNav Infusion System for hepatic arterial infusion of liver tumors; and the Pancreatic Retrograde Venous Infusion System for pancreatic tumors. It also develops SD-101, an investigational immunotherapeutic with pressure-enabled drug delivery technology for hepatocellular carcinoma, intrahepatic cholangiocarcinoma, uveal melanoma with liver metastases, pancreatic ductal adenocarcinoma with liver metastases, colorectal cancer with liver metastases, and primary pancreatic cancers. The company is based in Westminster, Colorado.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators